Therapeutic Asset Ratings

2,288 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Diluent Sjogren Syndrome	Instituto de Oftalmología Fundación Conde de Valenciana	P3	B (60)
Efruxifermin Metabolic Dysfunction-Associated Steatotic Liver Disease	Akero Therapeutics, Inc	P3	B (60)
Eloralintide Osteoarthritis	Eli Lilly and Company	P3	B (60)
Eloralintide Obstructive Sleep Apnea Syndrome	Eli Lilly and Company	P3	B (60)
FILGRASTIM Classic Hodgkin Lymphoma	National Cancer Institute (NCI)	P3	B (60)
FILGRASTIM Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	City of Hope Medical Center	P3	B (60)
FILGRASTIM Classic Hodgkin Lymphoma	Masonic Cancer Center, University of Minnesota	P3	B (60)
FILGRASTIM Colorectal Cancer	Roswell Park Cancer Institute	P3	B (60)
FILGRASTIM Nodal T-Follicular Helper Cell Lymphoma, Follicular Type	City of Hope Medical Center	P3	B (60)
FILGRASTIM Hodgkin'S Lymphoma, Lymphocytic-Histiocytic Predominance	National Cancer Institute (NCI)	P3	B (60)
FILGRASTIM Osteosarcoma	Albert Einstein College of Medicine	P3	B (60)
FILGRASTIM Overall Survival	Hospital General de Mexico	P3	B (60)
FILGRASTIM Pancreatic Neoplasm	General Oncology, Inc.	P3	B (60)
FILGRASTIM Primary Mediastinal Large B-Cell Lymphoma	National Research Center for Hematology, Russia	P3	B (60)
FILGRASTIM Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type	National Cancer Institute (NCI)	P3	B (60)
FILGRASTIM Survivorship	Shanghai Jiao Tong University School of Medicine	P3	B (60)
FILGRASTIM Toxicities	Shanghai Jiao Tong University School of Medicine	P3	B (60)
Genotropin Pituitary Deficiency	VA Office of Research and Development	P3	B (60)
Glatiramer Anti-CD20 Therapy	University Hospital, Montpellier	P3	B (60)
Histrelin Hypogonadism	SWOG Cancer Research Network	P3	B (60)
INCOBOTULINUMTOXINA Migraine Disorder	Uniformed Services University of the Health Sciences	P3	B (60)
Lanreotide Carcinoid Tumor	RayzeBio, Inc.	P3	B (60)
Lanreotide Gastroenteropancreatic Neuroendocrine Tumor Disease	RayzeBio, Inc.	P3	B (60)
Lanreotide Digestive System Neuroendocrine Neoplasm	RayzeBio, Inc.	P3	B (60)
Lanreotide Pancreatic Neuroendocrine Tumor	RayzeBio, Inc.	P3	B (60)

Showing 601 to 625 of 2,288 assets

PreviousPage 25 of 92Next